Skip to main content
SpringerLink
Log in

Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P (2015) Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17:1467–1507

    Article  PubMed  Google Scholar 

  2. Diener HC, Bernstein R, Butcher K, Campbell B, Cloud G, Davalos A, Davis S, Ferro JM, Grond M, Krieger D, Ntaios G, Slowik A, Touzé E (2017) Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: expert opinion. Int J Stroke 12:9–12

    Article  CAS  PubMed  Google Scholar 

  3. Kafke W, Kraft P (2016) Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a case report. Case Rep Neurol 8:140–144

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gawehn A, Ayari Y, Heuschkel C, Kaste M, Kermer P (2016) Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report. J Med Case Rep 10:269

    Article  PubMed  PubMed Central  Google Scholar 

  5. Berrouschot J, Stoll A, Hogh T, Eschenfelder CC (2016) Intravenous thrombolysis with recombinant tissue-type plasminogen activator in a stroke patient receiving dabigatran anticoagulant after antagonization with idarucizumab. Stroke 47:1936–1938

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Cliniques Universitaires St-Luc, 10 Avenue Hippocrate 10, 1200, Brussels, Belgium

    G. Turine & A. Peeters

  2. Haemostasis and Thrombosis Unit, Division Haematology, Cliniques Universitaires Luc, 10 Avenue Hippocrate 10, 1200, Brussels, Belgium

    C. Hermans

  3. Haemostasis and Thrombosis Laboratory, Department of Clinical Biology, Cliniques Universitaires Saint-Luc, 1200, Brussels, Belgium

    S. Eeckhoudt

  4. Neuroradiology Section, Department of Radiology, Cliniques Universitaires UCL St-Luc, 10 Avenue Hippocrate 10, 1200, Brussels, Belgium

    T. Duprez

Authors
  1. G. Turine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Peeters
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Hermans
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Eeckhoudt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Duprez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Turine.

Ethics declarations

Funding

None.

Conflict of interest

Gaëtane Turine declares that she has no conflict of interest. André Peeters has received a speaker honorarium of Boehringer-Ingelheim. Cédric Hermans has received a speaker honorarium of Boehringer-Ingelheim. Stéphane Eeckhoudt declares he has no conflict of interest. Thierry Duprez declares that he has no conflict of interest.

Ethical approval

For this type of study formal consent is not required.

Informed consent

Informed consent was obtained from all participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Turine, G., Peeters, A., Hermans, C. et al. Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer. Acta Neurol Belg 117, 753–755 (2017). https://doi.org/10.1007/s13760-017-0751-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-017-0751-5

Keywords

Search

Navigation